Skip Navigation
Toggle Menu
News & Events
Careers
Contact
About us
Background
History
Vision & Mission
Board of Directors
Suven Neuro
Locations
Business Segments
Contract Research And Manufacturing Services (C.R.A.M.S)
Intermediates
Active Pharma Ingredients
Drug Discovery & Development Support Services (DDDSS)
Synthetic and Medicinal Chemistry
Analytical Chemistry
In vitro Biology
ADME
Pharmacology
Toxicology
Bioanalysis
NCE Formulations
Drug Discovery & Research/Clinical pipeline
SUVN-502
SUVN-G3031
SUVN-D4010
SUVN-911
SUVN-I6107
Clinical Pipeline
Research Pipeline
Patent Portfolio
Research Publications
Formulation Development
Dossiers
Investors
Financial Info
Quarterly Release
Annual Reports
Subsidiary Accounts
Share Holder’s Info
Statutory Communications
Stock Information
AGM
EGM
Postal Ballot
Notice of Board Meeting
Un-paid Dividends
Scheme of Arrangement
Others
Corporate Info
Presentations
Advertisements
Credit Rating
Business Segments
Share Holder Contacts
Share Registry Services
Patent Updates
Corporate Governance
Committees of Board
Directors Familiarization program
Terms and conditions of appointment of ID’s
Policies
Code of Conduct
Sustainability
IMS Policy
Certifications & Awards
CSR Policies
CSR Gallery
Search
Presentations to Analysts/Investors
Home
Investors
Corporate Info
Presentations to Analysts/Investors
Corporate Presentations
View PDF